Deprince Race & Zollo Inc / BMY
Deprince Race & Zollo Inc’s Bristol-Myers Squibb Co Position
Does Deprince Race & Zollo Inc own Bristol-Myers Squibb Co (BMY)? Not currently — the last reported position was 506.1K shares worth $29M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$29M
Q3 2023
Shares
506.1K
% of Portfolio
+0.71%
Quarters Held
19
position exited
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 506.1K | $29M | +0.71% |
| Q2 2023 | 464.7K | $30M | +0.68% |
| Q1 2023 | 359.8K | $25M | +0.58% |
| Q4 2022 | 364.9K | $26M | +0.60% |
| Q3 2022 | 405.3K | $29M | +0.74% |
| Q2 2022 | 403.4K | $31M | +0.72% |
| Q1 2022 | 515.9K | $38M | +0.73% |
| Q4 2021 | 591.3K | $37M | +0.94% |
| Q3 2021 | 473.3K | $28M | +0.75% |
| Q2 2021 | 481.7K | $32M | +0.81% |
| Q1 2021 | 469.9K | $30M | +0.80% |
| Q4 2020 | 383.7K | $24M | +0.75% |
| Q3 2020 | 329.0K | $20M | +0.74% |
| Q2 2020 | 264.6K | $16M | +0.60% |
| Q1 2020 | 317.8K | $18M | +0.81% |
| Q4 2019 | 380.3K | $24M | +0.74% |
| Q3 2019 | 524.8K | $27M | +0.77% |
| Q2 2019 | 477.1K | $22M | +0.60% |
| Q1 2019 | 420.4K | $20M | +0.55% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deprince Race & Zollo Inc’s full portfolio or all institutional holders of BMY.